ArticleMolecular cancer therapeutics2016

Dual mTORC1/2 Inhibition as a Novel Strategy for the Resensitization and Treatment of Platinum-Resistant Ovarian Cancer.

Fernanda Musa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.